Reprogramming of human cancer cells to pluripotency for models of cancer progression

EMBO Journal

Volumn 34, Issue 6, 2015, Pages 739-747

  Kim, Jungsun ^a   Zaret, Kenneth S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

cancer; iPS; pluripotency; progression

Indexed keywords

CANCER CELL; CANCER CONTROL; CANCER GROWTH; CELL MATURATION; CHRONIC MYELOID LEUKEMIA; DIGESTIVE SYSTEM CANCER; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; MELANOMA; NEURAL STEM CELL; NONHUMAN; NUCLEAR REPROGRAMMING; PANCREAS ADENOCARCINOMA; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW; SARCOMA; SOMATIC CELL; ANIMAL; BIOLOGICAL MODEL; CELL NUCLEUS TRANSPLANTATION; DISEASE COURSE; INDUCED PLURIPOTENT STEM CELL; METABOLISM; MOUSE; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALIA; IPS;

TRANSCRIPTION FACTOR;

ANIMALS; CELLULAR REPROGRAMMING; DISEASE PROGRESSION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; MODELS, BIOLOGICAL; NEOPLASMS; NUCLEAR TRANSFER TECHNIQUES; TRANSCRIPTION FACTORS;

EID: 84924917212     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.15252/embj.201490736     Document Type: Review

References (74)

1. Abad M, Mosteiro L, Pantoja C, Canamero M, Rayon T, Ors I, Grana O, Megias D, Dominguez O, Martinez D, Manzanares M, Ortega S, Serrano M, (2013) Reprogramming in vivo produces teratomas and iPS cells with totipotency features. Nature 502: 340-345
2. Ablain J, Zon LI, (2013) Of fish and men: using zebrafish to fight human diseases. Trends Cell Biol 23: 584-586
3. Adamson ED, (1987) Oncogenes in development. Development 99: 449-471
4. Arteaga CL, Adamson PC, Engelman JA, Foti M, Gaynor RB, Hilsenbeck SG, Limburg PJ, Lowe SW, Mardis ER, Ramsey S, Rebbeck TR, Richardson AL, Rubin EH, Weiner GJ, Sweeney SM, Honey K, Bachen J, Driscoll P, Hobin J, Ingram J, et al, (2014) AACR cancer progress report 2014. Clin Cancer Res 20: S1-S112
5. Bar-Nur O, Russ HA, Efrat S, Benvenisty N, (2011) Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet Beta cells. Cell Stem Cell 9: 17-23
6. Begley CG, Ellis LM, (2012) Drug development: raise standards for preclinical cancer research. Nature 483: 531-533
7. Blelloch RH, Hochedlinger K, Yamada Y, Brennan C, Kim M, Mintz B, Chin L, Jaenisch R, (2004) Nuclear cloning of embryonal carcinoma cells. Proc Natl Acad Sci USA 101: 13985-13990
8. Bracken AP, Kleine-Kohlbrecher D, Dietrich N, Pasini D, Gargiulo G, Beekman C, Theilgaard-Monch K, Minucci S, Porse BT, Marine JC, Hansen KH, Helin K, (2007) The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev 21: 525-530
9. Braun AC, (1959) A demonstration of the recovery of the crown-gall tumor cell with the use of complex tumors of single-cell origin. Proc Natl Acad Sci USA 45: 932-938
10. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE, (1994) Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 8: 27-32
11. Cantley LC, Dalton WS, DuBois RN, Finn OJ, Futreal PA, Golub TR, Hait WN, Lozano G, Maris JM, Nelson WG, Sawyers CL, Schreiber SL, Spitz MR, Steeg PS, (2012) AACR cancer progress report 2012. Clin Cancer Res 18: S1-S100
12. Carette JE, Pruszak J, Varadarajan M, Blomen VA, Gokhale S, Camargo FD, Wernig M, Jaenisch R, Brummelkamp TR, (2010) Generation of iPSCs from cultured human malignant cells. Blood 115: 4039-4042
13. Chin L, Tam A, Pomerantz J, Wong M, Holash J, Bardeesy N, Shen Q, O'Hagan R, Pantginis J, Zhou H, Horner JW 2nd, Cordon-Cardo C, Yancopoulos GD, DePinho RA, (1999) Essential role for oncogenic RAS in tumour maintenance. Nature 400: 468-472
14. Dawson MA, Kouzarides T, (2012) Cancer epigenetics: from mechanism to therapy. Cell 150: 12-27
15. DePinho RA, (2000) The age of cancer. Nature 408: 248-254
16. Doi A, Park IH, Wen B, Murakami P, Aryee MJ, Irizarry R, Herb B, Ladd-Acosta C, Rho J, Loewer S, Miller J, Schlaeger T, Daley GQ, Feinberg AP, (2009) Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 41: 1350-1353
17. Esteller M, (2007) Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 8: 286-298
18. von Figura G, Fukuda A, Roy N, Liku ME, Morris Iv JP, Kim GE, Russ HA, Firpo MA, Mulvihill SJ, Dawson DW, Ferrer J, Mueller WF, Busch A, Hertel KJ, Hebrok M, (2014) The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma. Nat Cell Biol 16: 255-267
19. Gao D, Vela I, Sboner A, Iaquinta PJ, Karthaus WR, Gopalan A, Dowling C, Wanjala JN, Undvall EA, Arora VK, Wongvipat J, Kossai M, Ramazanoglu S, Barboza LP, Di W, Cao Z, Zhang QF, Sirota I, Ran L, MacDonald TY, et al, (2014) Organoid cultures derived from patients with advanced prostate cancer. Cell 159: 176-187
20. Gurdon JB, Elsdale TR, Fischberg M, (1958) Sexually mature individuals of Xenopus laevis from the transplantation of single somatic nuclei. Nature 182: 64-65
21. Hochedlinger K, Blelloch R, Brennan C, Yamada Y, Kim M, Chin L, Jaenisch R, (2004) Reprogramming of a melanoma genome by nuclear transplantation. Genes Dev 18: 1875-1885
22. Hochedlinger K, Yamada Y, Beard C, Jaenisch R, (2005) Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 121: 465-477
23. Ishizawa K, Rasheed ZA, Karisch R, Wang Q, Kowalski J, Susky E, Pereira K, Karamboulas C, Moghal N, Rajeshkumar NV, Hidalgo M, Tsao M, Ailles L, Waddell TK, Maitra A, Neel BG, Matsui W, (2010) Tumor-initiating cells are rare in many human tumors. Cell Stem Cell 7: 279-282
24. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, Hong SM, Fu B, Lin MT, Calhoun ES, Kamiyama M, Walter K, Nikolskaya T, Nikolsky Y, Hartigan J, Smith DR, et al, (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321: 1801-1806
25. Kadoch C, Hargreaves DC, Hodges C, Elias L, Ho L, Ranish J, Crabtree GR, (2013) Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. Nat Genet 45: 592-601
26. Kim J, Hoffman JP, Alpaugh RK, Rhim AD, Reichert M, Stanger BZ, Furth EE, Sepulveda AR, Yuan CX, Won KJ, Donahue G, Sands J, Gumbs AA, Zaret KS, (2013) An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progression. Cell Rep 3: 2088-2099
27. Kim K, Zhao R, Doi A, Ng K, Unternaehrer J, Cahan P, Huo H, Loh YH, Aryee MJ, Lensch MW, Li H, Collins JJ, Feinberg AP, Daley GQ, (2011) Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat Biotechnol 29: 1117-1119
28. Kumano K, Arai S, Hosoi M, Taoka K, Takayama N, Otsu M, Nagae G, Ueda K, Nakazaki K, Kamikubo Y, Eto K, Aburatani H, Nakauchi H, Kurokawa M, (2012) Generation of induced pluripotent stem cells from primary chronic myelogenous leukemia patient samples. Blood 119: 6234-6242
29. Kumar SM, Liu S, Lu H, Zhang H, Zhang PJ, Gimotty PA, Guerra M, Guo W, Xu X, (2012) Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation. Oncogene 31: 4898-4911
30. Ledford H, (2011) Translational research: 4 ways to fix the clinical trial. Nature 477: 526-528
31. Li L, Connelly MC, Wetmore C, Curran T, Morgan JI, (2003) Mouse embryos cloned from brain tumors. Cancer Res 63: 2733-2736
32. Li X, Nadauld L, Ootani A, Corney DC, Pai RK, Gevaert O, Cantrell MA, Rack PG, Neal JT, Chan CW, Yeung T, Gong X, Yuan J, Wilhelmy J, Robine S, Attardi LD, Plevritis SK, Hung KE, Chen CZ, Ji HP, et al, (2014) Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture. Nat Med 20: 769-777
33. Lin TP, (1966) Microinjection of mouse eggs. Science 151: 333-337
34. Liu S, Leach SD, (2011) Zebrafish models for cancer. Annu Rev Pathol 6: 71-93
35. McKinnell RG, Deggins BA, Labat DD, (1969) Transplantation of pluripotential nuclei from triploid frog tumors. Science 165: 394-396
36. Melo JV, Barnes DJ, (2007) Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat Rev Cancer 7: 441-453
37. Mintz B, Illmensee K, (1975) Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc Natl Acad Sci USA 72: 3585-3589
38. Miyoshi N, Ishii H, Nagai K, Hoshino H, Mimori K, Tanaka F, Nagano H, Sekimoto M, Doki Y, Mori M, (2010) Defined factors induce reprogramming of gastrointestinal cancer cells. Proc Natl Acad Sci USA 107: 40-45
39. Muller R, Slamon DJ, Tremblay JM, Cline MJ, Verma IM, (1982) Differential expression of cellular oncogenes during pre- and postnatal development of the mouse. Nature 299: 640-644
40. Murphy SJ, Hart SN, Lima JF, Kipp BR, Klebig M, Winters JL, Szabo C, Zhang L, Eckloff BW, Petersen GM, Scherer SE, Gibbs RA, McWilliams RR, Vasmatzis G, Couch FJ, (2013) Genetic alterations associated with progression from pancreatic intraepithelial neoplasia to invasive pancreatic tumor. Gastroenterology 145: 1098-1109 e1091
41. Nardella C, Lunardi A, Patnaik A, Cantley LC, Pandolfi PP, (2011) The APL paradigm and the "co-clinical trial" project. Cancer Discov 1: 108-116
42. Nguyen LV, Vanner R, Dirks P, Eaves CJ, (2012) Cancer stem cells: an evolving concept. Nat Rev Cancer 12: 133-143
43. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weslon A, Modali R, Harris CC, Vogelstein B, (1989) Mutations in the p53 gene occur in diverse human tumour types. Nature 342: 705-708
44. Ohgaki H, Kleihues P, (2013) The definition of primary and secondary glioblastoma. Clin Cancer Res 19: 764-772
45. Ohnishi K, Semi K, Yamamoto T, Shimizu M, Tanaka A, Mitsunaga K, Okita K, Osafune K, Arioka Y, Maeda T, Soejima H, Moriwaki H, Yamanaka S, Woltjen K, Yamada Y, (2014) Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation. Cell 156: 663-677
46. Pachnis V, Mankoo B, Costantini F, (1993) Expression of the c-ret proto-oncogene during mouse embryogenesis. Development 119: 1005-1017
47. Pfeifer-Ohlsson S, Goustin AS, Rydnert J, Wahlstrom T, Bjersing L, Stehelin D, Ohlsson R, (1984) Spatial and temporal pattern of cellular myc oncogene expression in developing human placenta: implications for embryonic cell proliferation. Cell 38: 585-596
48. Pfeifer-Ohlsson S, Rydnert J, Goustin AS, Larsson E, Betsholtz C, Ohlsson R, (1985) Cell-type-specific pattern of myc protooncogene expression in developing human embryos. Proc Natl Acad Sci USA 82: 5050-5054
49. Postovit LM, Seftor EA, Seftor RE, Hendrix MJ, (2006) A three-dimensional model to study the epigenetic effects induced by the microenvironment of human embryonic stem cells. Stem Cells 24: 501-505
50. Postovit LM, Margaryan NV, Seftor EA, Kirschmann DA, Lipavsky A, Wheaton WW, Abbott DE, Seftor RE, Hendrix MJ, (2008) Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc Natl Acad Sci USA 105: 4329-4334
51. Ram O, Goren A, Amit I, Shoresh N, Yosef N, Ernst J, Kellis M, Gymrek M, Issner R, Coyne M, Durham T, Zhang X, Donaghey J, Epstein CB, Regev A, Bernstein BE, (2011) Combinatorial patterning of chromatin regulators uncovered by genome-wide location analysis in human cells. Cell 147: 1628-1639
52. Rangarajan A, Weinberg RA, (2003) Opinion: comparative biology of mouse versus human cells: modelling human cancer in mice. Nat Rev Cancer 3: 952-959
53. Rivlin N, Katz S, Doody M, Sheffer M, Horesh S, Molchadsky A, Koifman G, Shetzer Y, Goldfinger N, Rotter V, Geiger T, (2014) Rescue of embryonic stem cells from cellular transformation by proteomic stabilization of mutant p53 and conversion into WT conformation. Proc Natl Acad Sci USA 111: 7006-7011
54. Sabapathy K, Klemm M, Jaenisch R, Wagner EF, (1997) Regulation of ES cell differentiation by functional and conformational modulation of p53. EMBO J 16: 6217-6229
55. Sanchez MJ, Holmes A, Miles C, Dzierzak E, (1996) Characterization of the first definitive hematopoietic stem cells in the AGM and liver of the mouse embryo. Immunity 5: 513-525
56. Shain AH, Giacomini CP, Matsukuma K, Karikari CA, Bashyam MD, Hidalgo M, Maitra A, Pollack JR, (2012) Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer. Proc Natl Acad Sci USA 109: E252-E259
57. Sharma SV, Haber DA, Settleman J, (2010) Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents. Nat Rev Cancer 10: 241-253
58. Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S, Kotb M, Gillies SD, King M, Mangada J, Greiner DL, Handgretinger R, (2005) Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 174: 6477-6489
59. Singhal N, Graumann J, Wu G, Arauzo-Bravo MJ, Han DW, Greber B, Gentile L, Mann M, Scholer HR, (2010) Chromatin-remodeling components of the BAF complex facilitate reprogramming. Cell 141: 943-955
60. Slamon DJ, Cline MJ, (1984) Expression of cellular oncogenes during embryonic and fetal development of the mouse. Proc Natl Acad Sci USA 81: 7141-7145
61. Stricker SH, Feber A, Engstrom PG, Caren H, Kurian KM, Takashima Y, Watts C, Way M, Dirks P, Bertone P, Smith A, Beck S, Pollard SM, (2013) Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent manner. Genes Dev 27: 654-669
62. Suva ML, Riggi N, Bernstein BE, (2013) Epigenetic reprogramming in cancer. Science 339: 1567-1570
63. Takahashi K, Yamanaka S, (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676
64. Tentler JJ, Tan AC, Weekes CD, Jimeno A, Leong S, Pitts TM, Arcaroli JJ, Messersmith WA, Eckhardt SG, (2012) Patient-derived tumour xenografts as models for oncology drug development. Nat Rev Clin Oncol 9: 338-350
65. Thompson SL, Compton DA, (2010) Proliferation of aneuploid human cells is limited by a p53-dependent mechanism. J Cell Biol 188: 369-381
66. Tuveson DA, Jacks T, (2002) Technologically advanced cancer modeling in mice. Curr Opin Genet Dev 12: 105-110
67. Verbeek BS, Vroom TM, Adriaansen-Slot SS, Ottenhoff-Kalff AE, Geertzema JG, Hennipman A, Rijksen G, (1996) c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis. J Pathol 180: 383-388
68. Wang ZQ, Kiefer F, Urbanek P, Wagner EF, (1997) Generation of completely embryonic stem cell-derived mutant mice using tetraploid blastocyst injection. Mech Dev 62: 137-145
69. Wang ZY, Chen Z, (2008) Acute promyelocytic leukemia: from highly fatal to highly curable. Blood 111: 2505-2515
70. Wilkinson DG, Bailes JA, McMahon AP, (1987) Expression of the proto-oncogene int-1 is restricted to specific neural cells in the developing mouse embryo. Cell 50: 79-88
71. Wilson BG, Roberts CW, (2011) SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer 11: 481-492
72. Wu M, Jung L, Cooper AB, Fleet C, Chen L, Breault L, Clark K, Cai Z, Vincent S, Bottega S, Shen Q, Richardson A, Bosenburg M, Naber SP, DePinho RA, Kuperwasser C, Robinson MO, (2009) Dissecting genetic requirements of human breast tumorigenesis in a tissue transgenic model of human breast cancer in mice. Proc Natl Acad Sci USA 106: 7022-7027
73. Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, Kamiyama M, Hruban RH, Eshleman JR, Nowak MA, Velculescu VE, Kinzler KW, Vogelstein B, Iacobuzio-Donahue CA, (2010) Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467: 1114-1117
74. Zhang X, Cruz FD, Terry M, Remotti F, Matushansky I, (2013) Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming. Oncogene 32: 2249-2260, 2260 e2241-2221